The Patent Finder
US

Methods of Making Bempedoic Acid and Compositions of the Same

US 12,404,227 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Jul 13, 2026 (Biopharma Credit PLC).

Term ends Oct 31, 2040 · High confidence

Filed Aug 16, 2023 as application 18/450,591 · Granted Sep 2, 2025
Base term plus 134 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2020 2040
Clock starts
Jun 19, 2020
Term ends
Oct 31, 2040
Granted
Sep 2, 2025
base term patent term adjustment Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
134
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 134 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 19, 2020, when application PCT/US2020/038622, the earliest non-provisional in its chain, was filed (this one was filed Aug 16, 2023)Jun 19, 2040High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+134 days, USPTO patent term adjustment recordOct 31, 2040High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 31, 2040High confidence

This family

Application PCT/US2020/038622PCT application
no patent term
no patent term
Application 17/150,321Abandoned
not computed
not computed
US 11,407,705In force
Jun 2040
Jun 2040
US 11,760,714In force
Jun 2040
Jun 2040
US 11,613,511In force
Jun 2040
Jun 2040
US 11,987,548In force
no later than Jun 2040
no later than Jun 2040
US 11,926,584In force
no later than Jun 2040
no later than Jun 2040
US 12,404,227this patent
Oct 2040
Oct 2040
8 of 12 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 8, 2024
Reel 66048, frame 362
Abdelnasser, MohamedEsperion Therapeutics, Inc.Assignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 513
Copp, Richard; Cimarusti, Christopher M.Esperion Therapeutics, Inc.Assignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 529
Selig, PhilippPatheon Austria GmbH & Co. KGAssignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 540
Patheon Austria GmbH & Co. KGEsperion Therapeutics, Inc.Assignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 561
Lane, Jonathan; Barkman, Michael; Amin, Rasidul; Frank, MichelleCorden Pharma Colorado, Inc.Assignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 570
Corden Pharma Colorado, Inc.Esperion Therapeutics, Inc.Assignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 576
Cooper, Arthur John; Gopal, DamodaragounderOlon Ricerca Bioscience LLCAssignment of Assignor's Interest
Jan 8, 2024
Reel 66048, frame 583
Olon Ricerca Bioscience LLCEsperion Therapeutics, Inc.Assignment of Assignor's Interest
Dec 13, 2024
Reel 69582, frame 756
Esperion Therapeutics, Inc.Glas Americas LLCSecurity Interest
Jul 13, 2026
Reel 75952, frame 812
Esperion Therapeutics, Inc.; Resq Pharmaceuticals LLCBiopharma Credit PLC, as Collateral AgentPatent Security Agreement
Jul 14, 2026
Reel 75267, frame 816
Glas Americas LLCEsperion Therapeutics Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited